Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SHMT1P1 (SHMT-ps1) is a processed pseudogene originating from the cytosolic serine hydroxymethyltransferase 1 gene (SHMT1). It is located on the short arm of chromosome 1 and exists specifically in the primate order, having arisen via reverse transcription after the divergence of primates from other mammals. SHMT1P1 contains unique sequence features—such as deletions, insertions, and single-base mutations—used to track primate phylogenetics and molecular lineage. Unlike its functional parent gene, SHMT1, SHMT1P1 does not encode an active protein or contribute to metabolic processes, disease mechanisms, or serve as a therapeutic target[2][1][3][5].
Not applicable; as a non-functioning pseudogene, there is no mechanism of action relevant to pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine hydroxymethyltransferase 1 pseudogene 1 (SHMT1P1).